Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Aralez Pharmaceuticals
Yahoo Beta:1.21

Company Description:  Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada, Ireland, and the United States. The company engages in acquiring, developing, and commercializing products primarily in cardiovascular disease, pain, and other specialty areas.

Purchase Date:30 Jan 2013 Sale Date:19 Oct 2016
Purchase Price:$5.37 Sale Price:$4.82
  --Split Adjusted:$5.37  --Split Adjusted:$4.82
Shares Purchased:550 Shares Sold:250
  --Split Adjusted:550  --Split Adjusted:250
Transaction Fee:$9.99 Transaction Fee:$9.99
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$6.77 High$0.00
Date17 Aug 2012 Date01 Jan 1996
Low$4.98 Low$0.00
Date28 Dec 2012 Date01 Jan 1996
S&P (Purchase Date):$1,501.96 S&P (Sale Date):$2,148.01

Timing:  We bought in the middle of the six month range.
Reason:  We were highly impressed by the company's pipeline of future drugs.

Timing:  0
Reason:  ARLZ continues to sell current drugs in its portfolio, but has failed to develop a viable pipeline.

S&P Gain: 43.01 % Annualized Gain: 10.35%
Stock Gain: -10.29 % Annualized Gain: -2.94%

Net Holding Return ($): $-158.18
Net Holding Return (%): -11.7 %